Metabolic cardiomyopathies

International Journal of Experimental Pathology

Volumn 81, Issue 6, 2000, Pages 349-372

  Guertl, Barbara ^a,b   Noehammer, Christa ^a   Hoefler, Gerald ^a  

^a UNIVERSITY OF GRAZ   (Austria)

^b RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

Author keywords

Alcohol; Cardiomyopathy; Diabetes; Metabolic disorders; Mitochondria

Indexed keywords

ALCOHOLIC CARDIOMYOPATHY; CARDIOMYOPATHY; DIABETES MELLITUS; FATTY ACID METABOLISM; GLYCOGEN STORAGE DISEASE; HEART FAILURE; HEART MUSCLE METABOLISM; HUMAN; PRIORITY JOURNAL; REVIEW;

ADULT; ANIMALS; CALCIUM; CARDIOMEGALY; CARDIOMYOPATHIES; CARDIOMYOPATHY, ALCOHOLIC; CARNITINE; DIABETES MELLITUS; FATTY ACIDS; GLUCOSE; HEART FAILURE, CONGESTIVE; HUMANS; LYSOSOMAL STORAGE DISEASES; MALONYL COENZYME A; MITOCHONDRIAL MYOPATHIES; MUCOPOLYSACCHARIDOSES; MYOCARDIUM; OXIDATIVE PHOSPHORYLATION;

EID: 0034457799     PISSN: 09599673     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2613.2000.00186.x     Document Type: Review

References (203)

1. 2+ transport
2. Alcoholic cardiomyopathy in mice: Myocardial glycogen, lipids and certain enzymes
3. Alcoholic cardiomyopathy in mice, myocardial glycogen, lipids and certain enzymes
4. Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts
5. Clear correlation of genotype with disease phenotype in very-long-chain acyl-CoA dehydrogenase deficiency
6. Alterations in sarcoplasmic reticulum gene expression in human heart failure
7. Effects of fatty acids on Na/Ca exchange in cardiac sarcolemmal membranes
8. The feasibility of replacement therapy for inherited disorder of glycolysis: Triosephosphatisomerase deficiency
9. Myocardial metabolism in insulin-deficient diabetic humans without coronary artery disease
10. Malonyl-CoA metabolism in cardiac myocytes and its relevance to the control of fatty acid oxidation
11. X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): Respiratory x chain abnormalities in cultured fibroblasts
12. An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes
13. Histological and biochemical correlates of left ventricular chamber dynamics in man
14. Peripheral sensory-motor polyneuropathy, pigmentary retinopathy, and fatal cardiomyopathy in long-chain 3-hydroxy-acyl-CoA dehydrogenase deficiency
15. Mitochondrial complex deficiencies in a male with cardiomyopathy and 3-methylglutaconic aciduria
16. Transcriptional regulation of metabolic processes: Implications for cardiac metabolism
17. Requirement for the heart-type fatty acid binding protein in cardiac fatty acid utilization
18. Increased glycolytic metabolism in cardiac hypertrophy and congestive heart failure
19. Cardiac involvement in Sandhoff's disease. Inborn error of glycosphingolipid metabolism
20. Gaucher disease with oculomotor apraxia and cardiovascular calcification (Gaucher type IIIC)
21. Arrhythmias and conduction defects as presenting symptoms of fatty acids oxidaton disorders in children
22. Myocardial cell damage by fatty acid ethyl esters
23. Influence of experimental diabetes on sarcoplasmic reticulum function in rat ventricular muscle
24. Differences in cardiac calcium release channel (ryanodine receptor) expression in myocardium from patients with end-stage heart failure caused by ischemic versus dilated cardiomyopathy
25. Hemochromatosis: Genetic helps to define a multifactorial disease
26. Carnitine transporter OCTN2 mutations in systemic primary carnitine deficiency: A novel Arg169Gln mutation and a recurrent Arg282ter mutation associated with an unconventional splicing abnormality
27. Combined aortic and mitral valve replacement in an adult with Scheie's disease
28. Respiratory-chain and pyruvate metabolism defects: Italian collaborative survey on 72 patients
29. Calcification of the ascending aorta and aortic and mitral valves in Gaucher's disease
30. Perinatal hypothyroidism impairs the normal transition of GLUT4 and GLUT1 glucose transporters from fetal to neonatal levels in heart and brown adipose tissue
31. Unusual expression of Gaucher's disease: Cardiovascular calicifications in three sibs homozygous for the D409H mutation
32. The Gaucher registry, demographics and disease characteristics of 1698 patients with Gaucher disease
33. The effects of acute and chronic diabetes on myocardial metabolism in rats
34. Barth syndrome: Clinical observations and genetic linkage studies
35. Molecular basis of mitochondrial fatty acid oxidation defects
36. Glycogen storage disease type III (glycogen debranching enzyme deficiency): Correlation of biochemical defects with myopathy and cardiomyopathy
37. A pattern of accumulation of a somatic deletion of mitochondrial DNA in aging human tissues
38. The effects of novel vasodilator long chain acyl carnitine ester in the isolated perfused heart of the rat
39. Metabolic myopathies: A clinical approach
40. Secondary respiratory chain defect in a boy with long-chain 3-hydroxylacyl-CoA dehydrogenase deficiency: Possible diagnostic pitfalls
41. Paradoxical role of lipid metabolism in heart function and dysfunction
42. Effects of some L-carnitine derivatives on heart membrane ATPases
43. Hurler syndrome with cardiomyopathy in infancy
44. 3-Hydroxydicarboxylic aciduria due to long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency associated with sudden neonatal death: Protective effect of medium-chain triglycerid treatment
45. Insulin action on glucose transport in isolated cardiac myocytes: Signalling pathways and diabetes-induced alterations
46. Cardiac involvement by Gaucher's disease documented by right ventricular endomyocardial biopsy
47. Cytochrome P450, peroxisome proliferation and cytoplasmic fatty acid-binding protein content in liver, heart and kidney of the diabetic rat
48. Mitochondrial respiratory chain complex I deficiency with clinical and biochemical features of long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency
49. A novel MHC class I-like gene is mutated in patients with hereditary hemochromatosis
50. Disorders of propionate and methylmalonate metabolism
51. Glucose transport and glucose transporter GLUT4 are regulated by product (s) of intermediary metabolism in cardiomyocytes
52. Insulin-induced recruitment of glucose transporter 4 (GLUT4) and GLUT1 in isolated rat cardiac myocytes
53. Glycolysis and glucose oxidation during reperfusion of ischemic hearts from diabetic rats
54. Primary carnitine deficiency: Heterozygote and intrafamilial phenotypic variation
55. Effects of diabetes on myocardial glucose transport system in rats: Implications for diabetic cardiomyopathy
56. Cellular fatty acid-binding proteins: Their function and physiological significance
57. Rat heart fatty acid-binding protein content is increased in experimental diabetes
58. The capillary transport system for free fatty acids in the heart
59. Heart CD36 expression is increased in murine models of diabetes and in mice fed a high fat diet
60. Neonatal lethal mitochondrial trifunctional protein deficiency mimicking a respiratory chain defect
61. Echocardiographic features in the cardiac type of glycogen storage disease II
62. Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure
63. Brief report: A deficiency of carnitine-acylcarnitine translocase in the inner mitochondrial membrane
64. Identification of two novel mutations in the hypoglycemic phenotype of very long chain acyl-CoA dehydrogenase deficiency
65. Metabolic aspects of myocardial disease and a role for L-carnitine in the treatment of childhood cardiomyopathy
66. Type III mucopolysaccharidosis: Report of a case with severe mitral valve involvement
67. 2+ pump activity during diabetes mellitus
68. Deficiency of medium chain fatty acylcoenzyme A dehydrogenase presenting as the sudden infant death syndrome
69. Lethal neonatal multiorgan deficiency of carnitine palmitoyltransferase II
70. A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women
71. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: High frequency of the G1528C mutation with no apparent correlation with the phenotype
72. Mucopolysaccharidosis type IV as a cause of mitral stenosis in an adult
73. Long-chain 3-hydroxyl-CoA dehydrogenase deficiency
74. Echocardiographic abnormalities in type IV mucopolysaccharidosis
75. Diabetes and cardiovascular disease: The Framingham study
76. Role of diabetes in congestive heart failure: The framingham study
77. Differential regulation of calcium-dependent and calcium-independent cyclic nucleotide phosphodiesterases from heart by palmitoylcarnitine and palmitoyl coenzyme A
78. 2+-dependent protein kinases in heart, and inhibition of their phosphorylation by palmitoylcarnitine
79. Lipid membrane interactions and the pathogenesis of ischemic damage in the myocardium
80. Inherited cardiomyopathies
81. Detection and assessment by positron emission tomography of a genetically determined defect in myocardial fatty acid utilization (long-chain acyl-CoA dehydrogenase deficiency)
82. Lipolysis in isolated myocardial cells from diabetic rat hearts
83. Infantile cardiomyopathy and neuromyopathy with,-galactosidase deficiency
84. +-ATPase by palmitoyl carnitine: Potentiation by propanolol
85. Cardiomyopathy in glycogen-storage disease type III: Clinical and echographic study of 18 patients
86. The varied clinical and laboratory manifestations of type II Gaucher's disease
87. Myocardial metabolites of ethanol
88. Mitochondrial dysfunction induced by fatty acid ethyl esters, myocardial metabolites of alcohol
89. Presence of non-oxidative ethanol metabolism in human organs commonly damaged by ethanol abuse
90. Progressive increase of the mutated mitochondrial DNA fraction in Kearns-Sayre syndrome
91. Plasma creatine kinase and cardiomyopathy in glycogen storage disease type III
92. Mitochondrial respiratory chain disorders I: Mitochondrial defects
93. A transgenic model of acetaldehyde overproduction accelerates alcoholic cardiomyopathy
94. Effects of free fatty acids on mechanical and metabolic function in normal and ischemic myocardium in swine
95. Fatty acid β-oxidation deficiency masquerading as fulminant myocarditis
96. Regulation of fatty acid oxidation in the mammalian heart in health and disease
97. Protein-mediated palmitate uptake and expression of fatty acid transport proteins in heart giant vesicles
98. Hypertriglyceridemia is exacerbated by slow lipolysis of triacylglycerol-rich lipoproteins in fed but not fasted streptozotocin diabetic rats
99. Cardiac mitochondrial dysfunction and DNA depletion in children with hypertrophic cardiomyopathy
100. Mitochondrial function in children with idiopathic dilated cardiomyopathy
101. Novel mutations in mitochondrial cytochrome b in fatal post partum cardiomyopathy
102. Dilated cardiomyopathy caused by plasma membrane carnitnine transport defect
103. Lethal dilated cardiomyopathy due to long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency
104. Cardiomyopathy in propionic acidaemia
105. Myocardial free carnitine and fatty acylcarnitine levels in patients with chronic heart failure
106. Regulation of very-low-density lipoprotein receptor in hypertrophic rat heart
107. Malonic aciduria and cardiomyopathy
108. Molecular heterogeneity in very-long-chain acylCoA dehydrogenase deficiency causing pediatric cardiomyopathy and sudden death
109. Molecular lesion in patients with medium-chain acyl-CoA dehydrogenase deficiency
110. Two novel missense mutations of the OCTN2 gene (W283R and V446F) in a patient with primary systemic carnitine deficiency
111. Effect of palmitoylcarnitine on the passive electrical properties of isolated guinea pig ventricular myocytes
112. Muopolysaccharidosis type VI presenting in infancy with endocardial fibroelastosis and heart failure
113. Cardiac Hypertrophy and failure - A disease of adaptation
114. Cardiac involvement in glycogen storage disease type III
115. Ca2+ uptake by cardiac sarcoplasmic reticulum from patients with idiopathic dilated cardiomyopathy
116. Identification of two variant short chain acyl-coenzyme A dehydrognase alleles, each containing a different point mutation in a patient with short-chain acyl-coenyzme A dehydrogenase deficiency
117. Scintigraphic evidence for a specific long-chain fatty acid transporting system deficit and the genetic background in a patient with hypertrophic cardiomyopathy
118. The Mucopolysaccharidosis
119. A patient with lethal cardiomyopathy and a carnitine-acylcanrnitine translocase deficiency
120. Lethal neonatal deficiency of carnitine palmitoyltransferase II associated with dysgenesis of the brain and kidneys
121. I-cell disease: Clinical studies of 21 Japanese cases
122. Lipoprotein composition as a component in the lipoprotein clearance defect in experimental diabetes
123. Metabolism of the heart in health and disease
124. Effect of fatty acids on contractility and rhythm of the heart
125. Multiple mitochondrial DNA deletions exist in cardiomyocytes of patients with hypertrophic or dilated cardiomyopathy
126. Inhibition of enzyme activities by free fatty acids
127. Acute, severe cardiomyopathy as main symptom of late-onset very long-chain acyl-coenzyme A dehydrogenase deficiency
128. The effects of alcohol on the heart
129. Endogenous triacylglycerol metabolism in diabetic heart
130. A sensitive immunoassay for rat fatty acid translocase (CD 36) using phage antibodies selected on cell transfectants: Abundant presence of fatty acid translocase/CD 36 in cardiac and red skeletal muscle and upregulation in diabetes
131. Salient effects of L-carnitine on adenine-nucleotide loss and coenzyme A acylation in the diabetic heart perfused with excess palmitic acid
132. 2+ binding by and composition of the cardiac sarcolemmal membrane in chronic diabetes
133. NADH-coenzyme Q reductase (complex I) deficiency: Heterogeneity in phenotype and biochemical findings
134. Palmitylcarnitine inhibition of the calcium pump in cardiac sarcoplasmic reticulum: A possible role in myocardial ischemia
135. Clinical and molecular heterogeneity in very-long-chain acyl-coenzyme A dehydrogenase deficiency
136. Cytochrome oxidase immunohistochemistry: Clues for genetic mechanisms
137. The glucose fatty acid cycle: Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus
138. Evidence for cardiomyopathy in familial diabetes mellitus
139. Deficiency of long-chain 3-hydroxyl-CoA dehydrogenase: A cause of lethal myopathy and cardiomyopathy in early childhood
140. Molecular and physiological alterations in murine ventricular dysfunction
141. Myocardial substrate metabolism: Implications for diabetic cardiomyopathy
142. The diabetic heart: Causes for the development of a cardiomyopathy
143. The energy substrate switch during development of heart failure: Gene regulatory mechanisms
144. A role for Sp and nuclear receptor transcription factors in a cardiac hypertrophic growth program
145. Fatty acid oxidation enzyme gene expression is downregulated in the failing heart
146. MCD encodes peroxisomal and cytoplasmic forms of malonyl-CoA decarboxylase and is mutated in malonyl-CoA decarboxylase deficiency
147. Acetyl-CoA Carboxylase regulation of fatty acid oxidation in the heart
148. Myocardial triglyceride turnover and contribution to energy substrate utilization in isolated working rat hearts
149. Mechanisms of arrhythmias induced by palmitylcarnitine in guinea pig papillary muscle
150. Metabolism of VLDL is increased in streptozotocin-induced diabetic rat hearts
151. Gaucher's disease with mitral and aortic involvement: Echocardiogrpahic findings
152. Metabolic factors in myocardial failure
153. The symptomytology, morphology and biochemistry of glycogenosis type II (Pompe) in the adult
154. Development of obstruction to ventricular outflow and impairment of inflow in glycogen storage disease of the heart: Serial echcardiographic studies from birth to death at 6 months
155. Clinical heterogeneity in infantile galactosialidosis
156. Gaucher's disease with mitral valve calcification
157. Acylcarnitine in fibroblasts of patients with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency and other fatty acid oxidation disorders
158. Fatty acid and glucose metabolism in the perfused heart
159. Synthesis of ventricular mitochondrial proteins in vivo: Effect of acute ethanol toxicity
160. Prenatal hypertrophic cardiomyopathy and pericardial effusion in carbohydrate-deficient glycoprotein syndrome
161. 2+ channels by palmitoyl carnitine, a putative endogenous ligand
162. Decreased myocardial glucose uptake during ischemia in diabetic swine
163. Regulation of energy substrate metabolism in the diabetic heart
164. Chronic cardiomyopathy and weakness or acute coma in children with a defect in carnitine uptake
165. The genetic basis of pediatric cardiovascular disease
166. Molecular basis of human mitochondrial very-long-chain acyl-CoA dehydrogenase deficiency causing cardiomyopathy and sudden death in childhood
167. Combined deficiency of beta-galactosidase and neuraminidase: Natural history of the disease in the first 18 years of an American patient with late infantile onset form
168. Inherited idiopathic dilated cardiomyopathy with multiple deletions of mitochondrial DNA
169. Valvular heart disease in four patients with Maroteaux-Lamy syndrome
170. Mitochondrial mutation in fatal infantile cardiomyopathy
171. Mutations of OCTN2, an organic cation/carnitine transporter, lead to a deficient cellular carnitine uptake in primary carnitine deficiency
172. IIe in fatal cardiomyopathy
173. Molecular characterization of inherited carnitine palmitoyltransferase II deficiency
174. Fatty acid mitochondrial,-oxidation and hypoglycaemia in children
175. Short-chain acyl-CoA dehydrogenase deficiency, a cause of ophthalmoplegia and multicore myopathy
176. Impaired skin fibroblast uptake in primary systemic carnitine deficiency manifested by childhood carnitine-responsive cardiomyopathy
177. Systemic carnitine deficiency presenting as familial endocardial fibroelastosis
178. Abnormal myocardial kinetics of 1231-heptadecanoic acid in subjects with impaired glucose tolerance
179. Long-chain 3-hydroxyl-CoA dehydrogenase deficiency
180. Long-chain 3-hydroxyl-coenzyme A dehydrogenase deficiency with the G1528C mutation: Clinical presentation of thirteen patients
181. Hypoparathyroidism in a patient with long-chain 3-hydroxyacyl-coenzyme a dehydrogenase deficiency caused by the G1528C mutation
182. The effects of alcoholism on skeletal and cardiac muscle
183. A mechanism for reduced myocardial carnitine levels in diabetic animals
184. Effect of increased afterload on cardiac lipoprotein lipase and VLDL receptor expression
185. Cardiac fatty acid uptake and transport in health and disease
186. Mitochondrial very long-chain acyl-coenzyme A dehydrogenase deficiency: Clinical characteristics and diagnostic considerations in 30 patients
187. Maroteaux-Lamy syndrome: Five novel mutations and their structural localization
188. Carnitine deficiency presenting as familial cardiomyopathy: A treatable defect in carnitine transport
189. Mitochondrial defects in cardiomyopathy and neuromuscular disease
190. Sequence analysis of cDNAs for the human and bovine ATPsynthase, subunit: Mitochondrial DNA genes sustain seventeen times more mutations
191. Human trifunctional protein deficiency: A new disorder of mitochondrial fatty acid,-oxidation
192. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: Different clinical expression in three unrelated patients
193. A missense mutation in the OCTN2 gene associated with residual carnitine transport activity
194. Hypertrophic cardiomyopathy with type 1 CD36 deficiency
195. Endocardial fibroelastosis and Niemann-Pick disease
196. Cardiomyopathy in childhood, mitochondrial dysfunction and the role of L-carnitine
197. +-ATPase by palmitylcarnitine and palmityl-CoA
198. Palmitoyl carnitine modifies sodium current and induces transient inward current in ventricular myocytes
199. A new case of malonyl coenzyme A decarboxylase deficiency presenting with cardiomyopathy
200. Molecular basis of medium chain acyl-coenzyme A dehydrogenase deficiency. An A to G transition at position 985 that causes a lysine-304 to glutamate substitution in the mature protein is the single prevalent mutation
201. The natural history of the severe form of Hunter's syndrome: A study based on 52 cases
202. Maternally inherited myopathy and cardiomyopathy: Association with mutation in mitochondrial DNA tRNA Leu (UUR)
203. Deletions of mitochondrial DNA in Kearns-Sayre syndrome